Cardiovascular Risk Factor, HIV
Conditions
Brief summary
The overall objective of this project is to develop and rigorously test implementation strategies to address the gap in scientific knowledge of lower use of evidence-based interventions commonly referred to as the ABCS (aspirin, blood pressure control, cholesterol control, and smoking cessation)which contributes to the growing CVD morbidity and mortality among PLH.
Detailed description
Our project has two major aims: Aim 1: To assess the impact of the implementation of an evidence-based, multilevel strategy to reduce cardiovascular vascular disease (CVD) among PLH. Aim 2: To assess the process of implementation of these strategies using RE-AIM QuEST. Using both quantitative and qualitative methods, we evaluate the process of implementation by assessing Reach, \[Effectiveness addressed in Aim 1\], Adoption, Implementation and Maintenance whilst integrating Qualitative Evaluation for Systematic Translation.
Interventions
BEHAVIORALABCS training
Clinicians and patients will be given information regarding the ABCS (Aspirin, Blood Pressure control,Cholesterol control, and Smoking Cessation) and for reducing CVD risk among HIV patients.
Sponsors
Clinical Directors Network
University of Texas
National Heart, Lung, and Blood Institute (NHLBI)
University of Rochester
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
A stratified clustered randomized stepped wedge design.
Eligibility
Sex/Gender
ALL
Age
40 Years to 79 Years
Healthy volunteers
No
Inclusion criteria
Sites: * Serve a cohort of at least 100 HIV patients * Have an Electronic Health Record (EHR) * Agree to collaborate on implementing feasible adaptations of intervention strategies Patients: * Patient of the site with a diagnosis of HIV * Age 40-79 years * ≥5% risk for CVD as calculated using the ASCVD Risk Estimator Plus * Willing to participate * No plans to leave the site in the next 12 months * Proficient in either English or Spanish * Own a cell phone with texting capabilities Clinicians: * Physicians, Physicians Assistants, or Nurse Practitioners who provide direct HIV care to patients * Work at a participating site * Willing to implement the project's intervention strategies
Exclusion criteria
Patients: * Currently participating in another CVD trial * Have experienced a prior cardiac or vascular event such as myocardial infarction (MI) or cerebrovascular accident (CVA) * Have had a CVD procedure such as installation of a stent or angioplasty * Have peripheral vascular disease, intermittent claudication or peripheral arterial disease * Are pregnant * Lacks capacity to consent Clinicians: • Planning to leave the site within the next 12 months
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| 10-year CVD risk reduction | 12 months | This will be based on the ACVSD risk calculator |
Countries
United States
Outcome results
None listed